Your browser doesn't support javascript.
loading
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
Bahlis, Nizar J; Costello, Caitlin L; Raje, Noopur S; Levy, Moshe Y; Dholaria, Bhagirathbhai; Solh, Melhem; Tomasson, Michael H; Damore, Michael A; Jiang, Sibo; Basu, Cynthia; Skoura, Athanasia; Chan, Edward M; Trudel, Suzanne; Jakubowiak, Andrzej; Gasparetto, Cristina; Chu, Michael P; Dalovisio, Andrew; Sebag, Michael; Lesokhin, Alexander M.
Afiliación
  • Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada. nbahlis@ucalgary.ca.
  • Costello CL; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Raje NS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Levy MY; Department of Medical Oncology, Baylor Scott and White Health, Dallas, TX, USA.
  • Dholaria B; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Solh M; Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.
  • Tomasson MH; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
  • Damore MA; Oncology Research and Development, Pfizer Inc., San Diego, CA, USA.
  • Jiang S; Early Clinical Development, Pfizer Inc., San Diego, CA, USA.
  • Basu C; Early Clinical Development, Pfizer Inc., San Diego, CA, USA.
  • Skoura A; Early Clinical Development, Pfizer Inc., Collegeville, PA, USA.
  • Chan EM; Oncology Research and Development, Pfizer Inc., South San Francisco, CA, USA.
  • Trudel S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Jakubowiak A; Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.
  • Gasparetto C; Department of Medicine, Duke University Cancer Institute, Durham, NC, USA.
  • Chu MP; Cross Cancer Institute, Edmonton, AB, Canada.
  • Dalovisio A; Department of Hematology and Oncology, Ochsner Health, New Orleans, LA, USA.
  • Sebag M; Cedars Cancer Center, McGill University Health Center, Montreal, QC, Canada.
  • Lesokhin AM; Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, NY, USA.
Nat Med ; 29(10): 2570-2576, 2023 10.
Article en En | MEDLINE | ID: mdl-37783970
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anemia / Mieloma Múltiple Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anemia / Mieloma Múltiple Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Canadá